Seized drugs
Comparative Analysis of Gamma-Hydroxybutyrate and Gamma-Hydroxyvalerate Using GC/MS and HPLC
Does Recent Physical and Sexual Victimization Affect Further Substance Use for Adult Drug-Involved Offenders?
Police Perceptions of Street-Level Narcotics Activity: Evaluating Drug Buys as a Research Tool
The 'Hound' Can Sniff
Elimination of 7-Aminoflunitrazepam and Flunitrazepam in Urine After a Single Dose of Rohypnol
Crack, Street Gangs, and Violence
Narcotics and Crime: A Causal Modeling Approach
Qualitative Analysis and Detection of the Pyrolytic Products of JWH-018 and 11 Additional Synthetic Cannabinoids in the Presence of Common Herbal Smoking Substrates
Novel Technique Improves Analysis of Thermally Unstable Illicit Drugs
Recreational Research: Analyzing "Designer Drugs" at Miami's Premier Electronic Music Festival
Recent Advances in Comprehensive Chromatographic Analysis of Emerging Drugs
Quantification of Cocaine in Ternary Mixtures Using Partial Least Squares Regression Applied to Raman and Fourier Transform Infrared Spectroscopy
Video: Advances in Investigative Techniques: Drug Monitoring Programs
Office of Justice Programs (OJP) / Centers for Disease Control and Prevention (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the U.S. Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen MDI systems and support death investigation services practiced by medical examiner and coroner offices (MECs) across the United States. The MDI-IWG commenced in...